Medical Digest & Congress Report

Dr. Aurélien Delluc highlights key advancements in Venous Thromboembolism (VTE) diagnosis from the ISTH 2026 Congress.

Video: https://medicaldigest.org/scientific-contents/interview:vte-diagnosis-whats-new

Dr. Rebecca Edelmayer presents an inspiring overview of the latest breakthroughs and novelties in the treatment of Alzheimer's disease at the AAIC 2026 Congress.

Video: https://medicaldigest.org/scientific-contents/interview:novelties-treatment-alzheimers-disease

Dr. Courtney Kloske delivers a highly anticipated expert overview of the most impactful breakthroughs and scientific updates presented at the AAIC 2026 Congress. This concise brief highlights accelerated advances in early diagnostics, emerging multi-omics approaches, key clinical trial outcomes, and global initiatives shaping the future of Alzheimer's and dementia research.

Video: https://medicaldigest.org/scientific-contents/interview:highlights-aaic-2026-congress

Dr. Emanuel Della Torre discusses the clinical evidence behind targeting CD19+ B-cells in IgG4-related disease in a post-congress interview following EULAR 2026. This recap focuses on the therapeutic impact of these strategies, underlying immunological mechanisms, and the long-term management implications for patients in clinical practice.

Video: https://medicaldigest.org/scientific-contents/interview:targeting-cd19-b-cells-igg4-related-disease-clinical-evidence-and-implications-long-term-management

Professor Laura C. Coates highlights the rapidly evolving landscape of state-of-the-art treatments for psoriatic arthritis (PsA) in a post-congress interview following EULAR 2026. This recap focuses on personalized management pathways, novel targeted therapies, and strategic frameworks aimed at optimizing long-term patient outcomes.

Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-psoriatic-arthritis

Professor Elena Nikiphorou discusses the ongoing paradigm shift in rheumatoid arthritis (RA), presented at the EULAR 2026 Congress. This recap focuses on novel insights into RA pathogenesis and explores the promising therapeutic pipeline, highlighting how these scientific advancements are translating into more targeted, effective management strategies for clinical practice.

Video: https://medicaldigest.org/scientific-contents/interview:ra-paradigm-shift-new-insights-pathogenesis-and-pipeline-promise

Professor Oliver Distler dives into the complex landscape of systemic sclerosis (SSc), presented at the EULAR 2026 Congress. This recap focuses on recent breakthroughs in deciphering SSc pathogenesis, identifying and managing critical comorbidities, and evaluating emerging therapeutic strategies that pave the way for highly targeted clinical treatments.

Video: https://medicaldigest.org/scientific-contents/interview:systemic-sclerosis-deciphering-pathogenesis-unveiling-comorbidities-and-paving-way-targeted-treatment

Professor Lorenzo Cavagna discusses the developed EULAR / ACR classification criteria for anti-synthetase syndrome, presented at the EULAR 2026 Congress. This recap highlights the critical diagnostic parameters, clinical features, and serological markers involved in these standardized criteria, aiming to improve early recognition and harmonize research and patient care globally.

Video: https://medicaldigest.org/scientific-contents/interview:eular-acr-classification-criteria-anti-synthetase-syndrome

Professor Annelies Boonen explores systemic workflows and their critical role in advancing global healthcare within rheumatology, presented at the EULAR 2026 Congress. This recap highlights optimized clinical pathways, health economics, and strategic workflow improvements designed to enhance patient care and sustainability on a global scale.

Video: https://medicaldigest.org/scientific-contents/interview:workflow-focus-advancing-global-health-rheumatology

Professor Radmila Matijevic addresses the complexities of diagnosing osteoporosis within the context of inflammatory rheumatic conditions, presented at the EULAR 2026 Congress. This recap focuses on best practices for early identification, the impact of chronic inflammation on bone density, and diagnostic strategies to effectively assess fracture risk in this specific patient population.

Video: https://medicaldigest.org/scientific-contents/interview:diagnosing-osteoporosis-inflammatory-rheumatic-conditions